BeOne Medicines (BEIGF) Non-cash Items (2016 - 2017)
BeOne Medicines (BEIGF) reported Non-cash Items of $10.4 million for Q4 2017, up 721.89% year-over-year from $1.3 million in Q4 2016, and up 721.89% quarter-over-quarter from $1.3 million in Q4 2016.
BeOne Medicines (BEIGF) Non-cash Items (2016 - 2017) Analysis & Trends
BeOne Medicines (BEIGF) has 2 years of Non-cash Items data on file, last reported at $10.4 million in Q4 2017.
- Non-cash Items for Q4 2017 came in at $10.4 million, up 721.89% year-over-year; the trailing twelve-month figure through Dec 2017 was $10.4 million (up 721.89% YoY), and the FY2017 annual result was $10.4 million, up 721.89% from the prior year.
- Non-cash Items advanced to $10.4 million in Q4 2017 per BEIGF's latest filing, from $1.3 million in the prior quarter.
- Over five years, Non-cash Items peaked at $10.4 million in Q4 2017 and troughed at $1.3 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 10.42 Mn |
| Dec 31, 2017 | 10.42 Mn |
| Dec 31, 2016 | 1.27 Mn |
| Dec 31, 2016 | 1.27 Mn |